A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations-Reference-Cited by-同舟云学术

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations

Published:2019-07-29 Issue:8 Volume:28 Page:675-686
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Babiker Hani M¹,Davis Lisa¹,Larson Kristian¹,Placencia Crystal¹,Swensen Connor¹,Tenneti Pavan²,Lim Melissa¹,Cañamar Ruth¹,Curtis Jacqueline¹,Castillo Erica¹,Mancuso James³,Rensvold Diane¹,Martinez Sarah¹,Macias Lora¹,Recio-Boiles Alejandro¹,Chandana Sreenivasa R⁴,Mahadevan Daruka¹

Affiliation:

1. Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Early Phase Clinical Trials Program, Tucson, AZ, USA

2. Department of Medicine, Banner University Medical Center Phoenix, Phoenix, AZ, USA

3. Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

4. Department of Gastrointestinal Medical Oncology, Cancer and Hematology Centers of Western Michigan, Phase I Program, START Midwest, Grand Rapids, MI, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1646726

Reference37 articles.

1. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study

3. Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002

4. Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the pharmacist in research;Remington;2021

2. Understanding Breast cancer: from conventional therapies to repurposed drugs;European Journal of Pharmaceutical Sciences;2020-08